PetMed Express (NASDAQ: PETS) — Perfil da empresa, notícias e dados financeiros
PetMed Express is a US retailer specializing in prescription pet medications and health products for dogs and cats.
PetMed Express
PetMed Express (NASDAQ:PETS) specializes in the retail of prescription and non-prescription pet medications, as well as other health products for dogs and cats, directly to the consumer. The company operates primarily through its online platform and telephone contact center, aiming to offer convenience, competitive pricing, and a wide selection of products. PetMed Express, often known as simply 'PetMeds', focuses on improving pet health, leveraging easy access to affordable medication. Their objectives include expanding product lines, enhancing customer service, and implementing strategic marketing to foster growth and customer retention.
Resumo
Operações
Produtos e/ou serviços de PetMed Express
- Prescription and non-prescription pet medications for a variety of ailments and conditions, including heartworm, flea prevention, and arthritis.
- A wide range of pet supplies, including food, beds, and grooming products.
- Pet insurance plans offering coverage for accidents, illnesses, and routine care.
- Online veterinary telehealth services, providing pet owners access to veterinary consultations from home.
- Customized pet medication compounding service, allowing for personalized dosages and formulations.
- Educational resources for pet owners, including articles and videos on pet health, nutrition, and behavior.
equipe executiva do PetMed Express
- Douglas KrulikChief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer & Treasurer
- Leslie C. G. CampbellStrategic Advisor
- Jeffrey Allen WillardCEO, President & Director
- Andrew ParryChief Technology Officer
- Robert LawskyCorporate Secretary & General Counsel
- Jacqueline SmithVice President of People
- Caroline ConeglianoChief Growth Officer
- Wendy ZalaiCorporate Controller & Corporate Secretary
Histórico de dividendos
Dividendos por ação pagos pela PetMed Express, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2024 | — | — | — | $0.6000 |
| FY2023 | — | — | — | $1.2000 |
| FY2022 | — | — | — | $1.2000 |
| FY2021 | — | — | — | $1.1200 |
| FY2020 | — | — | — | $1.0800 |
Principais indicadores financeiros
Resultados divulgados pela PetMed Express, em USD.
- Cap. de mercado
- 25,6 mi
- Receita (TTM)
- 168,9 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.4
- Dividend yield
- —
- Margem de lucro
- -17.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 179 mi | -31,4 mi | -57,3 mi | |
| 274,1 mi | -7 mi | -7,5 mi | |
| 256,6 mi | 6,6 mi | 5,1 mi | |
| 273,4 mi | 25,7 mi | 21,1 mi |